Category: News

This past December, the Government of Canada announced support for 24 third-party science and research organizations – including BioCanRx – under the new Strategic Science Fund (SSF). We asked Dr. Michaud about the importance of this critical funding and what it means for the future work of BioCanRx – Canada’s Immunotherapy Network.   What does… Read more »

At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy.   BioCanRx is invested in… Read more »

  The third World Indigenous Cancer Conference (WICC) took place earlier this month in Naarm (Melbourne), Australia. WICC 2024 brought together speakers from around the world, key Indigenous cancer researchers, clinicians, advocates and community members to “identify international research priorities, foster new collaboration, enhance capacity and share knowledge and information about Indigenous people living with… Read more »

Dear colleagues and the broader community of cancer immunotherapy stakeholders,   As some of you are aware, BioCanRx – Canada’s Immunotherapy Network, was awarded funding through the Government of Canada’s Strategic Science Fund for the period of 2024-2029.   BioCanRx is a network of scientists, highly qualified personnel, clinicians, cancer stakeholders, NGOs and industry partners… Read more »

  BioCanRx is pleased to be named an I.D.E.A.L. Bioscience Employer™ for 2023-2024 by BioTalent Canada.   The I.D.E.A.L. Bioscience Employer Recognition Program recognizes health and biosciences organizations that embody the principles of inclusion, diversity, equity and accessibility leadership as best practices needed to advance innovations and promote the Canadian bio-economy as a global leader…. Read more »

  We all know someone in our circle of family, friends or colleagues who has had to deal with a cancer diagnosis. Cancer is the #1 leading cause of death in Canada accounting for 28% of all deaths in our country. According to Canadian Cancer Society (CCS) statistics, 2 in 5 Canadians will develop cancer… Read more »

    By Alexandria McRorie Member of the Métis Nation of Alberta, Region 3 Bachelor of Science Undergrad Student at the University of Calgary 2023 BioCanRx Summer Student   In November 2023, the Canadian Science Policy Conference (CSPC) featured a compelling panel discussion titled “Empowering Indigenous Youth in STEM: Best Engagement Practices.” This session was… Read more »

    ACCESS’ Education and Training Theme is calling for survey respondents to help them determine the educational needs of Canadian pediatric clinicians, research staff, researchers, and trainees.   This survey is open to: • Pediatric oncology clinicians/research staff (e.g nursing, pharmacy, CRAs, physicians, social work, psychologists amongst others) including trainees • Pediatric researchers including… Read more »

At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy.   BioCanRx is invested in… Read more »